(marketscreener.com) EDMONTON, Alberta, Feb. 23, 2024 -- Ceapro Inc. , today provided an update on its progress across its current business. On December 14, 2023, the Company announced it entered into a definitive agreement to combine operations with Aeterna Zentaris Inc. , a TSX and Nasdaq listed specialty biopharmaceutical company, in an all-stock merger of...https://www.marketscreener.com/quote/stock/CEAPRO-INC-29716823/news/Ceapro-Provides-Business-Update-on-Progress-of-Ongoing-Development-Programs-Technology-and-Cosmeceu-46018996/?utm_medium=RSS&utm_content=20240223